Bintie Biotechnology
About:
Bintie Biotechnology is a pioneering biomedical technology enterprise in the clinical stage.
Website: https://www.immuxell.cn
Top Investors: SDIC Venture Capital, Yuanxi Haihe Fund, Winguide Huangpu Pharmaceutical
Description:
Bintie Biotechnology is a pioneering biomedical technology enterprise in the clinical stage. Its primary products are novel immune cell formulations intended to target solid tumors.
Total Funding Amount:
100M CNY
Headquarters Location:
Pudong, Shandong, China
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-10-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai